Pharyngeal Neoplasms clinical trials
The registry lists 34 studies for Pharyngeal Neoplasms across more than 10 countries. 7 are recruiting or about to start. 8 of them are mainly about Pharyngeal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 4 narrower conditions too, such as Nasopharyngeal Carcinoma: 1,245 studies, 420 open.
Get an email when these change. Save the Pharyngeal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Alabama at Birmingham (2) · National Cancer Institute (NCI) (2) · M.D. Anderson Cancer Center (2) · Johnny Kao (2) · Lumina Pharmaceuticals Inc (1) · Taproot Health (1) · Azienda USL 4 Prato (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1)
What is being tested here
Drugs under test in Pharyngeal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Nov 2026Microbiome in Head and Neck Squamous Cell Carcinoma · University of Colorado, Denver
- Jun 2027Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy · Maria Sklodowska-Curie National Research Institute of Oncology
- Sep 2027Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · Lumina Pharmaceuticals Inc
Who these studies take
Of the 6 Pharyngeal Neoplasms studies recruiting now, 2 (33%) set no upper age limit and 2 (33%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (17%) | 1 (17%) |
| 18 | 6 (100%) | 6 (100%) |
| 30 | 6 (100%) | 6 (100%) |
| 40 | 6 (100%) | 6 (100%) |
| 50 | 6 (100%) | 6 (100%) |
| 65 | 6 (100%) | 6 (100%) |
| 75 | 5 (83%) | 5 (83%) |
| 85 | 4 (67%) | 4 (67%) |
Across all 34 studies, recruiting or not: 18% stop at 75 or younger and 9% at 65; 18% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Studies
Recruiting first, then most recently updated. Showing 34 of 34. search them.
- Biospecimen Procurement for Head and Neck DisordersRecruitingNCT034290361 country
- Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial)RecruitingNCT07851857Phase 31 country
- Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNot yet recruitingNCT07781852Early Phase 11 country
- Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx CancerRecruitingNCT05388773Phase 21 country
- Microbiome in Head and Neck Squamous Cell CarcinomaRecruitingNCT058372211 country
- Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.RecruitingNCT05719779Not applicable1 country
- A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck CancerRecruitingNCT05830240Early Phase 11 country
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 11 country
- Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose RadiotherapyActive, not recruitingNCT05992610Not applicable1 country
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 11 country
- Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable1 country
- SDF Application in Oral Cancer Patients to Prevent Dental CariesCompletedNCT05403125Early Phase 11 country
- Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomyCompletedNCT054979471 country
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT040284791 country
- Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)TerminatedNCT03769467Phase 1/21 country
- Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct LaryngoscopyCompletedNCT03653039Not applicable1 country
- A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersWithdrawnNCT04892875Phase 1
- Resistance Training and Physical Functioning in Head and Neck Cancer PatientsCompletedNCT01332682Phase 11 country
- Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck CancerCompletedNCT03067610Phase 21 country
- Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck CancerCompletedNCT010847331 country
- Patient Evaluation for Head and Neck Surgery Branch StudiesTerminatedNCT000114921 country
- Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/PharyngectomyTerminatedNCT034794631 country
- Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 11 country
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal CancerCompletedNCT02849327Phase 1/21 country
- Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)CompletedNCT00117572Phase 35 countries
- Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerCompletedNCT00462735Phase 21 country
- Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck CancerTerminatedNCT01216020Phase 21 country
- Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk PopulationCompletedNCT00359645Phase 31 country
- Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck CancerCompletedNCT00970502Phase 1/21 country
- Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal CancerCompletedNCT00827164Phase 21 country
- Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck CancerCompletedNCT00140556Early Phase 11 country
- Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or PharyngolaryngectomyStatus unknownNCT00396617Phase 11 country
- Study of Biomarker From Blood and Tissue of Head and Neck CarcinomaStatus unknownNCT01171235
- Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT000011671 country